Today: 19 June 2026
Browse Category

Earnings Reports 13 January 2026 - 14 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
Bank of America stock drops as Trump’s credit-card cap plan raises the stakes before earnings

Bank of America stock drops as Trump’s credit-card cap plan raises the stakes before earnings

Bank of America shares fell 1.2% to $54.54 in after-hours trading Tuesday as investors weighed a proposed 10% cap on credit-card interest rates. The move follows declines across big banks after Donald Trump called for the cap to start Jan. 20. Investors are focused on Bank of America’s net interest income and guidance ahead of quarterly results. U.S. December CPI rose 0.3%, adding pressure to the sector.
14 January 2026
··
Robinhood stock rises after CPI print; traders eye Fed decision and Feb earnings

Robinhood stock rises after CPI print; traders eye Fed decision and Feb earnings

Robinhood shares closed up 2.3% at $120.24 Tuesday, steady after hours, as December CPI held at 2.7% year-on-year. The inflation data kept attention on the upcoming Federal Reserve meeting Jan. 27-28 and Robinhood’s earnings set for Feb. 10. Richmond Fed President Tom Barkin called the inflation figures “encouraging.” Crypto and retail-trading stocks mostly tracked rate expectations.
14 January 2026
···
JPMorgan stock drops after earnings: Apple Card reserve, weak deal fees and what’s next for JPM shares

JPMorgan stock drops after earnings: Apple Card reserve, weak deal fees and what’s next for JPM shares

JPMorgan shares fell 4.2% to $310.90 in after-hours trading after fourth-quarter results showed a $2.2 billion reserve tied to the Apple Card and a 5% drop in investment banking fees. Net income was $13.0 billion, or $4.63 per share. Investors remain wary of possible U.S. credit card rate caps and await peer bank earnings.
13 January 2026
···
KNSA stock slides 6% after Kiniksa maps out $900–$920 million ARCALYST outlook — what’s next

KNSA stock slides 6% after Kiniksa maps out $900–$920 million ARCALYST outlook — what’s next

Kiniksa shares fell 6.1% to $38.61 Tuesday after the company projected 2026 ARCALYST revenue of $900–$920 million, below the prior year’s growth rate. The drop followed an intraday low of $38.27. Wedbush raised its price target to $50, citing increased prescriber numbers and longer therapy use. Kiniksa reported $677.5 million in 2025 ARCALYST revenue and ended the year with $414.1 million in cash.
13 January 2026
····
IBM stock drops 3% even after BofA lifts target — what to watch before earnings

IBM stock drops 3% even after BofA lifts target — what to watch before earnings

IBM shares fell about 3% Tuesday, underperforming a weaker U.S. market after Bank of America raised its price target but warned of a tougher 2026 setup. BofA expects $400 million in restructuring costs to weigh on fourth-quarter margins. Investors await IBM’s January 28 earnings for signals on software growth and cash flow. IBM’s $11 billion Confluent deal remains pending.
13 January 2026
··
Texas Instruments stock slips late in session as CPI hits tape and Jan. 27 earnings loom

Texas Instruments stock slips late in session as CPI hits tape and Jan. 27 earnings loom

Texas Instruments shares fell 0.5% to $188.12 Tuesday, lagging the broader chip sector as investors weighed new U.S. inflation data and awaited the company’s Jan. 27 earnings report. The iShares Semiconductor ETF rose 0.9%, while rivals Analog Devices and ON Semiconductor posted gains. U.S. consumer prices rose 0.3% in December, with core inflation up 2.6% year-over-year.
13 January 2026
·······
Verizon stock drops as FCC loosens phone unlocking rule and traders look to earnings next

Verizon stock drops as FCC loosens phone unlocking rule and traders look to earnings next

The FCC granted Verizon a waiver from its 60-day phone unlocking rule, allowing the carrier to follow broader industry standards. Verizon shares fell 2.4% to $38.89 Tuesday, underperforming peers after the decision. The company reported losing 784,703 devices to fraud in 2023. Verizon also amended a $30 million performance stock award for CEO Daniel H. Schulman.
13 January 2026
··
Pfizer stock slips as CEO likens obesity drugs to Viagra; Metsera trials and Feb. 3 earnings in focus

Pfizer stock slips as CEO likens obesity drugs to Viagra; Metsera trials and Feb. 3 earnings in focus

Pfizer shares fell 0.6% to $25.12 in Tuesday afternoon trading after CEO Albert Bourla discussed plans to accelerate obesity drug trials at the J.P. Morgan Healthcare Conference. Bourla said Pfizer aims to launch 10 Phase 3 trials for its Metsera portfolio by 2026 but does not expect revenue growth before 2029. Investors await the Feb. 3 earnings report for updates on the obesity pipeline and guidance.
13 January 2026
···
ServiceNow stock drops as Oppenheimer trims target — what to watch before earnings

ServiceNow stock drops as Oppenheimer trims target — what to watch before earnings

ServiceNow shares fell 3.3% to $137.95 Tuesday after Oppenheimer cut its price target to $200, citing sector concerns ahead of earnings. Goldman Sachs began coverage with a Buy rating and $205 target, while Citi maintained its Buy and placed the stock on a 30-day catalyst watch. The iShares Expanded Tech-Software ETF dropped 2%. Investors remain cautious after ServiceNow’s $7.75 billion Armis acquisition.
13 January 2026
··
AbbVie stock nudges lower after Trump drug-price pact; traders watch JPM talk, Feb. 4 results

AbbVie stock nudges lower after Trump drug-price pact; traders watch JPM talk, Feb. 4 results

AbbVie shares fell 0.1% to $219.83 Tuesday after announcing a three-year U.S. pricing deal tied to tariff exemptions. The company also signed a $650 million licensing agreement with China’s RemeGen for rights to an experimental cancer drug and bought a manufacturing site in Arizona. Management is set to speak at the J.P. Morgan Healthcare Conference on Jan. 14.
13 January 2026
··
Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus

Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus

Alnylam shares fell 0.1% to $370.39 Tuesday afternoon after the company projected 2026 net product revenue between $4.9 billion and $5.3 billion. Preliminary 2025 sales were disclosed at $2.987 billion. Analysts remained mostly positive but flagged possible weakness for Amvuttra next quarter. The update came as Alnylam outlined its new five-year strategy at the J.P. Morgan Healthcare Conference.
13 January 2026
··
Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola shares rose 0.5% to $70.83 Tuesday after the company set Feb. 10 for its Q4 and full-year earnings release and investor call. CEO-elect Henrique Braun and CFO John Murphy will speak at the CAGNY conference in Orlando on Feb. 17. Coke expects a $1 billion impairment charge in Q4 tied to its Africa bottling sale. PepsiCo shares gained 1.4% while the S&P 500 ETF slipped 0.4%.
13 January 2026
··
Wells Fargo stock slides ahead of earnings as credit-card rate cap talk rattles banks

Wells Fargo stock slides ahead of earnings as credit-card rate cap talk rattles banks

Wells Fargo shares fell 1.6% to $93.44 Tuesday, ahead of its fourth-quarter earnings release set for 7 a.m. ET Wednesday. The drop followed President Trump’s proposal for a 10% cap on credit card interest rates, which hit bank stocks. Trading volume reached 11.4 million shares. Investors are watching credit costs and margins amid policy uncertainty and fresh inflation data.
13 January 2026
··
Western Digital stock ticks up as WDC sets Jan. 29 earnings, putting AI storage demand in focus

Western Digital stock ticks up as WDC sets Jan. 29 earnings, putting AI storage demand in focus

Western Digital shares rose 1.6% to $215.57 on Tuesday, ahead of its fiscal Q2 results set for Jan. 29 after the market closes. The stock has swung sharply in recent sessions, fueled by AI-driven demand for storage and recent bullish comments from Nvidia’s CEO. Analysts expect quarterly EPS of $1.92 and revenue near $2.91 billion. Seagate also gained, while Micron fell 2.3%.
13 January 2026
····
1 … 145 146 147 148 149 … 257

Stock Market Today

  • JPMorgan European Discovery Trust Declares Final Dividend for 2026
    June 19, 2026, 3:16 AM EDT. JPMorgan European Discovery Trust plc announced a final dividend of 13.0 pence per share, pending shareholder approval at the upcoming Annual General Meeting. The dividend will be paid on August 3, 2026, to shareholders on record as of July 3, 2026, with an ex-dividend date of July 2, 2026. A dividend reinvestment plan is available, with the last election date set for July 13, 2026. The announcement was made by JPMorgan Funds Limited, the company's secretary, reflecting the trust's commitment to returning value to shareholders.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop